2017
A Case of Carbamazepine-induced Severe Cholestatic Hepatitis: Case Report and Review of Literature
Ganesh S, Shukla L, Kandasamy A, Benegal V. A Case of Carbamazepine-induced Severe Cholestatic Hepatitis: Case Report and Review of Literature. Indian Journal Of Psychological Medicine 2017, 39: 688-690. PMID: 29200572, PMCID: PMC5688903, DOI: 10.4103/ijpsym.ijpsym_19_17.Peer-Reviewed Case Reports and Technical NotesSevere cholestatic hepatitisCholestatic hepatitisDrug-induced liver injuryCausality assessment scaleFemale patient presentingInitiation of carbamazepineReview of literatureLiver injuryClinical manifestationsPatient presentingCase reportPrescribed drugsAssessment ScaleField of neuropsychiatryHepatitisCarbamazepinePatientsPresentingEtiopathogenesisInjury
2016
Seizure clusters: A common, understudied and undertreated phenomenon in refractory epilepsy
Komaragiri A, Detyniecki K, Hirsch LJ. Seizure clusters: A common, understudied and undertreated phenomenon in refractory epilepsy. Epilepsy & Behavior 2016, 59: 83-86. PMID: 27116535, DOI: 10.1016/j.yebeh.2016.02.030.Peer-Reviewed Original Research
2014
Searching for the Immune Basis of Obsessive-Compulsive Disorder
Teixeira AL, Rodrigues DH, Marques AH, Miguel EC, Fontenelle LF. Searching for the Immune Basis of Obsessive-Compulsive Disorder. NeuroImmunoModulation 2014, 21: 152-158. PMID: 24557049, DOI: 10.1159/000356554.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderImmune parametersAnti-basal ganglia antibodiesParticular immune profileRheumatic feverImmune profileComorbid conditionsImmune basisAutoimmune diseasesImmune cellsPsychotropic drugsClinical observationsObsessive-compulsive symptomsPatientsUnequivocal changesOCD patientsElevated frequencyDisordersFeverEtiopathogenesisCytokinesSymptomsDiseaseAntibodies
2006
Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)
Galan A, Cowper SE, Bucala R. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Current Opinion In Rheumatology 2006, 18: 614-617. PMID: 17053507, DOI: 10.1097/01.bor.0000245725.94887.8d.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsNephrogenic systemic fibrosisSystemic fibrosisNephrogenic fibrosing dermopathyRenal insufficiencyClinical awarenessSystemic diseaseClinical spectrumTreatment optionsFibrogenic factorsEffective therapyFatal disorderEnigmatic disorderClinical reportsCardinal featuresFibrosisSpecific causesDisordersPathogenesisFibrocytesFuture studiesCauseRheumatologistsPatientsEtiopathogenesisRegistry
1999
Neonatal Cholestasis: A Red Alert for the Jaundiced Newborn
Pashankar D, Schreiber R. Neonatal Cholestasis: A Red Alert for the Jaundiced Newborn. Canadian Journal Of Gastroenterology And Hepatology 1999, 14: 67d-72d. PMID: 11110615, DOI: 10.1155/2000/657368.Peer-Reviewed Original ResearchConceptsNeonatal cholestasisNeonatal cholestatic disordersBile acid metabolismPersistent jaundiceYounger patientsPrompt diagnosisCholestatic disordersBile flowNeonatal jaundiceConjugated hyperbilirubinemiaJaundiced newbornsCholestasisTherapeutic interventionsEarly interventionAcid metabolismJaundiceHyperbilirubinemiaNewbornsFurther investigationInterventionPatientsPrognosisEtiopathogenesisInfantsRed alert
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply